Selected research
Market Structure
Global Furosemide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Furosemide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Furosemide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Furosemide include Sun Pharm Inds, Sandoz, Sanofi Aventis, Mylan, West-Ward Pharms, US Pharm Holdings, Ivax Sub Teva Pharms, Hospira and Emcure Pharms, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Furosemide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Furosemide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Furosemide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Furosemide market size, projected growth trends, production technologies, key applications, and end-use industries.
Furosemide Segment by Company
Sun Pharm Inds
Sandoz
Sanofi Aventis
Mylan
West-Ward Pharms
US Pharm Holdings
Ivax Sub Teva Pharms
Hospira
Emcure Pharms
Furosemide Segment by Type
Injection
Solution
Tablet
Furosemide Segment by Application
Clinics
Hospital
Pharmacy
Others
Furosemide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Furosemide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Furosemide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Furosemide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Furosemide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Furosemide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Furosemide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Furosemide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Solution
- Tablet
Applications
- Clinics
- Hospital
- Pharmacy
- Others
Companies covered
- Sun Pharm Inds
- Sandoz
- Sanofi Aventis
- Mylan
- West-Ward Pharms
- US Pharm Holdings
- Ivax Sub Teva Pharms
- Hospira
- Emcure Pharms
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Furosemide Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Furosemide Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Furosemide Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Furosemide Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Furosemide Market Dynamics
- 2.1 Furosemide Industry Trends
- 2.2 Furosemide Industry Drivers
- 2.3 Furosemide Industry Opportunities and Challenges
- 2.4 Furosemide Industry Restraints
3 Furosemide Market by Manufacturers
- 3.1 Global Furosemide Revenue by Manufacturers (2021-2026)
- 3.2 Global Furosemide Sales by Manufacturers (2021-2026)
- 3.3 Global Furosemide Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Furosemide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Furosemide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Furosemide Manufacturers, Product Type & Application
- 3.7 Global Furosemide Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Furosemide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Furosemide Players Market Share by Revenue in 2025
- 3.8.3 2025 Furosemide Tier 1, Tier 2, and Tier 3
4 Furosemide Market by Type
- 4.1 Furosemide Type Introduction
- 4.1.1 Injection
- 4.1.2 Solution
- 4.1.3 Tablet
- 4.2 Global Furosemide Sales by Type
- 4.2.1 Global Furosemide Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Furosemide Sales by Type (2021-2032)
- 4.2.3 Global Furosemide Sales Market Share by Type (2021-2032)
- 4.3 Global Furosemide Revenue by Type
- 4.3.1 Global Furosemide Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Furosemide Revenue by Type (2021-2032)
- 4.3.3 Global Furosemide Revenue Market Share by Type (2021-2032)
5 Furosemide Market by Application
- 5.1 Furosemide Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospital
- 5.1.3 Pharmacy
- 5.1.4 Others
- 5.2 Global Furosemide Sales by Application
- 5.2.1 Global Furosemide Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Furosemide Sales by Application (2021-2032)
- 5.2.3 Global Furosemide Sales Market Share by Application (2021-2032)
- 5.3 Global Furosemide Revenue by Application
- 5.3.1 Global Furosemide Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Furosemide Revenue by Application (2021-2032)
- 5.3.3 Global Furosemide Revenue Market Share by Application (2021-2032)
6 Global Furosemide Sales by Region
- 6.1 Global Furosemide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Furosemide Sales by Region (2021-2032)
- 6.2.1 Global Furosemide Sales by Region (2021-2026)
- 6.2.2 Global Furosemide Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Furosemide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Furosemide Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Furosemide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Furosemide Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Furosemide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Furosemide Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Furosemide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Furosemide Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Furosemide Revenue by Region
- 7.1 Global Furosemide Revenue by Region
- 7.1.1 Global Furosemide Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Furosemide Revenue by Region (2021-2026)
- 7.1.3 Global Furosemide Revenue by Region (2027-2032)
- 7.1.4 Global Furosemide Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Furosemide Revenue (2021-2032)
- 7.2.2 North America Furosemide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Furosemide Revenue (2021-2032)
- 7.3.2 Europe Furosemide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Furosemide Revenue (2021-2032)
- 7.4.2 Asia-Pacific Furosemide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Furosemide Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Furosemide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sun Pharm Inds
- 8.1.1 Sun Pharm Inds Company Information
- 8.1.2 Sun Pharm Inds Business Overview
- 8.1.3 Sun Pharm Inds Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sun Pharm Inds Furosemide Product Portfolio
- 8.1.5 Sun Pharm Inds Recent Developments
- 8.2 Sandoz
- 8.2.1 Sandoz Company Information
- 8.2.2 Sandoz Business Overview
- 8.2.3 Sandoz Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sandoz Furosemide Product Portfolio
- 8.2.5 Sandoz Recent Developments
- 8.3 Sanofi Aventis
- 8.3.1 Sanofi Aventis Company Information
- 8.3.2 Sanofi Aventis Business Overview
- 8.3.3 Sanofi Aventis Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sanofi Aventis Furosemide Product Portfolio
- 8.3.5 Sanofi Aventis Recent Developments
- 8.4 Mylan
- 8.4.1 Mylan Company Information
- 8.4.2 Mylan Business Overview
- 8.4.3 Mylan Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Mylan Furosemide Product Portfolio
- 8.4.5 Mylan Recent Developments
- 8.5 West-Ward Pharms
- 8.5.1 West-Ward Pharms Company Information
- 8.5.2 West-Ward Pharms Business Overview
- 8.5.3 West-Ward Pharms Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 West-Ward Pharms Furosemide Product Portfolio
- 8.5.5 West-Ward Pharms Recent Developments
- 8.6 US Pharm Holdings
- 8.6.1 US Pharm Holdings Company Information
- 8.6.2 US Pharm Holdings Business Overview
- 8.6.3 US Pharm Holdings Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 US Pharm Holdings Furosemide Product Portfolio
- 8.6.5 US Pharm Holdings Recent Developments
- 8.7 Ivax Sub Teva Pharms
- 8.7.1 Ivax Sub Teva Pharms Company Information
- 8.7.2 Ivax Sub Teva Pharms Business Overview
- 8.7.3 Ivax Sub Teva Pharms Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ivax Sub Teva Pharms Furosemide Product Portfolio
- 8.7.5 Ivax Sub Teva Pharms Recent Developments
- 8.8 Hospira
- 8.8.1 Hospira Company Information
- 8.8.2 Hospira Business Overview
- 8.8.3 Hospira Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Hospira Furosemide Product Portfolio
- 8.8.5 Hospira Recent Developments
- 8.9 Emcure Pharms
- 8.9.1 Emcure Pharms Company Information
- 8.9.2 Emcure Pharms Business Overview
- 8.9.3 Emcure Pharms Furosemide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Emcure Pharms Furosemide Product Portfolio
- 8.9.5 Emcure Pharms Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Furosemide Value Chain Analysis
- 9.1.1 Furosemide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Furosemide Production Mode & Process
- 9.2 Furosemide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Furosemide Distributors
- 9.2.3 Furosemide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst